EUVIMEDEUVIMED entdecken
Crossref

T cell receptor precision editing of regulatory T cells for celiac disease

Raphaël Porret iD, Ana Alcaraz-Serna iD, Benjamin Peter iD, Jeremiah Bernier-Latmani iD, Rebecca Cecchin iD, Oscar Alfageme-Abello iD, Laura Ermellino iD, Morteza Hafezi iD, Eleonora Pace iD, M Fleur du Pré, Erica Lana, Dela Golshayan iD und 10 weitere

Science Translational Medicine · 2025

DOI: 10.1126/scitranslmed.adr8941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Raphaël Porret und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne CH-1005, Switzerland. Hauptthemen laut MEDLINE: Celiac Disease, T-Lymphocytes, Regulatory, Receptors, Antigen, T-Cell, Gene Editing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Celiac disease, a gluten-sensitive enteropathy, demonstrates a strong human leukocyte antigen (HLA) association, with more than 90% of patients carrying the HLA-DQ2.5 allotype. No therapy is available for the condition except for a lifelong gluten-free diet. To address this gap, we explored the therapeutic potential of regulatory T cells (T regs ). By orthotopic replacement of T cell receptors (TCRs) through homology-directed repair, we generated gluten-reactive HLA-DQ2.5–restricted CD4 + engineered (e) T effector cells (T effs ) and eT regs and performed in vivo experiments in HLA-DQ2.5 transgenic mice. Of five validated TCRs, TCRs specific for two immunodominant and deamidated gluten epitopes (DQ2.5-glia-α1a and DQ2.5-glia-α2) were selected for further evaluation. CD4 + eT effs exposed to deamidated gluten through oral gavage colocalized with dendritic and B cells in the Peyer’s patches and gut-draining lymph nodes and specifically migrated to the intestine. The suppressive function of human eT regs correlated with high TCR functional activity. eT regs specific for one epitope suppressed the proliferation and gut migration of CD4 + eT effs specific for the same and the other gluten epitope, demonstrating bystander suppression. The suppression requires an antigen-specific activation of eT regs given that polyclonal T regs failed to suppress CD4 + eT effs . These findings highlight the potential of gluten-reactive eT regs as a therapeutic for celiac disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseT-Lymphocytes, RegulatoryReceptors, Antigen, T-CellGene EditingAnimalsHumansMice, TransgenicGlutensMiceHLA-DQ AntigensEpitopes

Substanzen

Receptors, Antigen, T-CellGlutensHLA-DQ AntigensEpitopes

Autor:innen und Institutionen

  • Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne CH-1005, Switzerland.
  • Laboratories of Neuroimmunology, Service of Neurology and Neuroscience Research Center, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne CH-1005, Switzerland.
  • Department of Oncology, Lausanne University Hospital and University of Lausanne, 1005 Lausanne, Switzerland.
  • Norwegian Coeliac Disease Research Centre, Institute of Clinical Medicine, University of Oslo and Department of Immunology, Oslo University Hospital, Oslo NO-0424, Norway.
  • Transplantation Center, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne CH-1005, Switzerland.
  • Service of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne CH-1005, Switzerland.

ORCID-Profile: Raphaël Porret, Ana Alcaraz-Serna, Benjamin Peter, Jeremiah Bernier-Latmani, Rebecca Cecchin, Oscar Alfageme-Abello, Laura Ermellino, Morteza Hafezi, Eleonora Pace, Dela Golshayan, Dominique Velin, Justin Eyquem, Qizhi Tang, Tatiana V Petrova, George Coukos, Melita Irving, Caroline Pot, Giuseppe Pantaleo, Ludvig M Sollid, Yannick D Muller

Zitieren

APA

Porret, R., Alcaraz-Serna, A., Peter, B., Bernier-Latmani, J., Cecchin, R., Alfageme-Abello, O., Ermellino, L., Hafezi, M., Pace, E., du Pré, M. F., Lana, E., Golshayan, D., Velin, D., Eyquem, J., Tang, Q., Petrova, T. V., Coukos, G., Irving, M., Pot, C., …, & Muller, Y. D. (2025). T cell receptor precision editing of regulatory T cells for celiac disease. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adr8941

Vancouver

Porret R, Alcaraz-Serna A, Peter B, Bernier-Latmani J, Cecchin R, Alfageme-Abello O, et al. T cell receptor precision editing of regulatory T cells for celiac disease. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.adr8941

BibTeX
@article{Porret2025,
  author = {Porret, Raphaël and Alcaraz-Serna, Ana and Peter, Benjamin and Bernier-Latmani, Jeremiah and Cecchin, Rebecca and Alfageme-Abello, Oscar and Ermellino, Laura and Hafezi, Morteza and Pace, Eleonora and du Pré, M Fleur and Lana, Erica and Golshayan, Dela and Velin, Dominique and Eyquem, Justin and Tang, Qizhi and Petrova, Tatiana V and Coukos, George and Irving, Melita and Pot, Caroline and Pantaleo, Giuseppe and Sollid, Ludvig M and Muller, Yannick D},
  title = {T cell receptor precision editing of regulatory T cells for celiac disease},
  journal = {Science Translational Medicine},
  year = {2025},
  doi = {10.1126/scitranslmed.adr8941}
}
Kostenlos starten →